Therapeutic Areas: Oncology | Pediatrics/Neonatology | Neurology
A listing of Neuroblastoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
State
Country
Phoenix : Phoenix Children'S Hospital
Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma
Phoenix : Phoenix Children's Hospital
Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
Duarte : City of Hope Updated
COG ANBL00B1: Neuroblastoma Biology Studies
Los Angeles : Children's Hospital of Los Angeles
ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma
San Diego : Rady Children's Hospital
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Aurora : University of Colorado Health Sciences Center and The Children's Hospital
Hartford : Connecticut Children's Hospital
Orlando : Arnold Palmer Hospital for Children- MD Anderson
Savannah : Memorial University Medical Center
ACNS0821:Temozolomide With Irinotecan Versus Temozolomide, Irinotecan Plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial
Atlanta : Children's Healthcare of Atlanta Childern Hosp - ATL
A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB
Atlanta : Children's Healthcare of Atlanta - Egleston
Chicago : The University of Chicago
Baltimore : Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. John Hopkins
Bethesda : National Institutes of Health Clinical Center, 9000 Rockville Pike
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Boston : Dana Farber Cancer Institute DFCI (3)
Boston : Dana-Farber Cancer Institute
Ann Arbor : University of Michigan C.S. Mott Children's Hospital
Grand Rapids : Helen DeVos Children's Hospital
Minneapolis : Children's Hospitals and Clinics of Minnesota - Minneapolis
Kansas City : Children's Mercy Hospital (Kansas)
Kansas City : Children's Mercy Hospitals and Clinics
St. Louis : Washington University School of Medicine
St. Louis : Cardinal Glennon Children's Medical Center
Bronx : Children's Hospital at Montefiore
A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer
New York : Memorial Sloan Kettering Cancer Center
Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma
New York : Columbia University Medical Center
New York : Memorial Sloan-Kettering Cancer Center
Charlotte : Levine Children's Hospital
Durham : Duke University Medical Center
Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
131I-Metaiodobenzylguanidine (MIBG) with Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
131I-MIBG Expanded Access: An Open Label, Expanded Access Protocol Using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients With Refractory Neuroblastoma
Phase I Study of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb™ (LXS) Oral Powder In Patients with Recurrent or Resistant Neuroblastoma IND# 68,254
Philadelphia : Children's Hospital of Philadelphia
Pittsburgh : Children's Hospital of Pittsburgh
Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Charleston : Medical University of South Carolina
Austin : Dell Children's Blood and Cancer Center
Fort Worth : Cook Children's Medical Center
Houston : Texas Children's Cancer and Hematology Centers
Seattle : Seattle Children's Hospital CPKC412A2114
Seattle : Seattle Children's Hospital
Buenos Aires : Prof. Dr. J. P. Garrahan National Children's Hospital
Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides
Parkville : Novartis Investigative Site
Toronto : Novartis Investigative Site
Paris : Novartis Investigative Site
Villejuif Cedex : Novartis Investigative Site
Bologna : Novartis Investigative Site
Milano : Novartis Investigative Site
Newcastle Upon Tyne : Novartis Investigative Site
Sutton : Novartis Investigative Site